[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 138,201,904
  • Shares Outstanding, K 253,805
  • Annual Sales, $ 12,001 M
  • Annual Income, $ 3,953 M
  • EBIT $ 4,777 M
  • EBITDA $ 4,987 M
  • 60-Month Beta 0.30
  • Price/Sales 11.46
  • Price/Cash Flow 30.82
  • Price/Book 6.79

Options Overview Details

View History
  • Implied Volatility 27.75% (-0.94%)
  • Historical Volatility 28.78%
  • IV Percentile 28%
  • IV Rank 20.76%
  • IV High 46.24% on 02/12/26
  • IV Low 22.91% on 09/09/25
  • Expected Move (DTE 2) 7.14 (1.30%)
  • Put/Call Vol Ratio 1.89
  • Today's Volume 1,412
  • Volume Avg (30-Day) 2,408
  • Put/Call OI Ratio 0.95
  • Today's Open Interest 43,006
  • Open Int (30-Day) 49,256
  • Expected Range 540.51 to 554.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $4.37
  • Number of Estimates 6
  • High Estimate $4.46
  • Low Estimate $4.23
  • Prior Year $4.22
  • Growth Rate Est. (year over year) +3.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
465.51 +17.65%
on 08/04/26
555.69 -1.45%
on 08/25/26
+70.55 (+14.79%)
since 07/31/26
3-Month
420.01 +30.39%
on 06/03/26
555.69 -1.45%
on 08/25/26
+109.25 (+24.92%)
since 06/01/26
52-Week
374.17 +46.36%
on 09/24/25
555.69 -1.45%
on 08/25/26
+156.63 (+40.06%)
since 08/29/25

Most Recent Stories

More News
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

Crinetics acquisition completed September 1, 2026 Charles Wagner, EVP, Chief Operating and Financial Officer to take on expanded COO role overseeing integration of Crinetics,...

CRNX : 84.95 (+0.13%)
VRTX : 547.65 (+0.57%)
1 S&P 500 Stock with Exciting Potential and 2 We Ignore

1 S&P 500 Stock with Exciting Potential and 2 We Ignore

WFC : 87.04 (+0.75%)
VRTX : 547.65 (+0.57%)
GEHC : 70.42 (-1.14%)
Vertex to Participate in Upcoming September Investor Conferences

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in four upcoming investor conferences. Susie Lisa, Senior Vice President...

VRTX : 547.65 (+0.57%)
2 Large-Cap Stocks to Research Further and 1 We Question

2 Large-Cap Stocks to Research Further and 1 We Question

VRTX : 547.65 (+0.57%)
HWM : 254.89 (+4.06%)
MLM : 504.92 (-2.50%)
Are Wall Street Analysts Bullish on Vertex Stock?

Vertex Pharmaceuticals has raced ahead of the market, while analysts continue to give the stock a decidedly optimistic outlook.

XLV : 171.67 (+0.66%)
$SPX : 7,631.47 (-0.71%)
VRTX : 547.65 (+0.57%)
3 Cash-Producing Stocks on Our Watchlist

3 Cash-Producing Stocks on Our Watchlist

VRTX : 547.65 (+0.57%)
KRT : 47.45 (-0.40%)
YOU : 42.97 (-2.67%)
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Crinetics Pharmaceuticals...

CRNX : 84.95 (+0.13%)
VRTX : 547.65 (+0.57%)
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call

5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call

VRTX : 547.65 (+0.57%)
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q2 CY2026 Sales Expectations, Full-Year Outlook Slightly Exceeds Expectations

Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q2 CY2026 Sales Expectations, Full-Year Outlook Slightly Exceeds Expectations

VRTX : 547.65 (+0.57%)
Vertex: Q2 Earnings Snapshot

Vertex: Q2 Earnings Snapshot

VRTX : 547.65 (+0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 557.33
2nd Resistance Point 554.36
1st Resistance Point 551.01
Last Price 547.65
1st Support Level 544.69
2nd Support Level 541.72
3rd Support Level 538.37

See More

52-Week High 555.69
Last Price 547.65
Fibonacci 61.8% 486.35
Fibonacci 50% 464.93
Fibonacci 38.2% 443.51
52-Week Low 374.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.